Hormonal
Adipose tissue functions as an active endocrine organ that secretes adipocytokines (e.g., TNF-α, IL-6, leptin, adiponectin) which regulate whole-body metabolism, insulin sensitivity, and inflammation, rather than serving merely as inert fat storage.
Understand that your fat tissue is an active organ that sends signals to your brain and other organs. It doesn't just store energy; it regulates your appetite, insulin sensitivity, and inflammation through hormones like leptin and adiponectin. Managing fat mass is therefore managing a complex hormonal system, not just caloric storage.
Adipose tissue is no longer considered to be an inert tissue that stores fat... As an endocrine organ, adipose tissue is responsible for the synthesis and secretion of several hormones... This paper reviews some of the biochemical and metabolic aspects of adipose tissue and its relationship to inflammatory disease and insulin resistance.
Why this rating
This is a state-of-the-art review paper synthesizing extensive experimental data and established biological consensus.
Source
State of the art paper Biochemistry of adipose tissue: an endocrine organ
Marisa Coelho et al. · Archives of Medical Science · 2013
DOI 10.5114/aoms.2013.33181
More from this paper
- Obesity induces a state of chronic low-grade inflammation in adipose tissue, primarily driven by macrophage infiltration and the secretion of pro-inflammatory cytokines (TNF-α, IL-6), which directly impairs insulin signaling and contributes to insulin resistance.Strong
- Adiponectin is an adipokine secreted exclusively by adipose tissue that improves insulin sensitivity and fatty acid oxidation, with levels inversely correlated to fat mass, making its reduction in obesity a key factor in metabolic dysfunction.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →